Profit Or Loss [Abstract]

Embla Medical hf - Filing #5889952

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
854,889,000 USD
785,683,000 USD
Cost of sales
320,189,000 USD
300,110,000 USD
Gross profit
534,700,000 USD
485,573,000 USD
Profit (loss) from operating activities
113,153,000 USD
89,387,000 USD
Finance income
3,251,000 USD
4,608,000 USD
Finance costs
24,746,000 USD
20,720,000 USD
Profit (loss) before tax
90,563,000 USD
76,007,000 USD
Tax expense (income)
21,603,000 USD
17,206,000 USD
Profit (loss)
682,000 USD
68,960,000 USD
68,278,000 USD
68,278,000 USD
58,801,000 USD
412,000 USD
58,389,000 USD
58,389,000 USD
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
68,278,000 USD
58,389,000 USD
Profit (loss), attributable to non-controlling interests
682,000 USD
412,000 USD
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
0.162
0.140
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
0.162
0.140

Talk to a Data Expert

Have a question? We'll get back to you promptly.